Annovis Bio Financials
| ANVS Stock | USD 4.87 0.02 0.41% |
Annovis |
Understanding current and past Annovis Bio Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Annovis Bio's financial statements are interrelated, with each one affecting the others. For example, an increase in Annovis Bio's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Annovis Bio's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Annovis Bio. Check Annovis Bio's Beneish M Score to see the likelihood of Annovis Bio's management manipulating its earnings.
Annovis Bio Stock Summary
Annovis Bio competes with Cassava Sciences, Axsome Therapeutics, Reviva Pharmaceuticals, Seres Therapeutics, and Anavex Life. Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. The company was incorporated in 2008 and is based in Berwyn, Pennsylvania. Annovis Bio operates under Biotechnology classification in the United States and is traded on New York Stock Exchange. It employs 3 people.Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Instrument | USA Stock View All |
| Exchange | New York Stock Exchange |
| ISIN | US03615A1088 |
| CUSIP | 03615A108 |
| Location | Pennsylvania; U.S.A |
| Business Address | 101 Lindenwood Drive, |
| Sector | Biotechnology |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.annovisbio.com |
| Phone | 484 875 3192 |
| Currency | USD - US Dollar |
Annovis Bio Key Financial Ratios
| Return On Equity | -5.97 | ||||
| Return On Asset | -1.55 | ||||
| Target Price | 34.8 | ||||
| Beta | 1.7 |
Annovis Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Annovis Bio's current stock value. Our valuation model uses many indicators to compare Annovis Bio value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Annovis Bio competition to find correlations between indicators driving Annovis Bio's intrinsic value. More Info.Annovis Bio is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Annovis Bio by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Annovis Bio Systematic Risk
Annovis Bio's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Annovis Bio volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was sixty with a total number of output elements of one. The Beta measures systematic risk based on how returns on Annovis Bio correlated with the market. If Beta is less than 0 Annovis Bio generally moves in the opposite direction as compared to the market. If Annovis Bio Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Annovis Bio is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Annovis Bio is generally in the same direction as the market. If Beta > 1 Annovis Bio moves generally in the same direction as, but more than the movement of the benchmark.
Steps to analyze company Financials for Investing
There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines you should consider when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase yearly due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt-to-equity ratio because this number will tell you how much risk it has. If a company such as Annovis Bio is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to determine if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that the net revenue of Annovis has grown by more than 25% over the last five years, then there is a good chance that it will continue growing by at least 20% or more each year. On the other hand, if you see that net revenue has only increased by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it. In summary, you can determine if Annovis Bio's financials are consistent with your investment objective using the following steps:- Review Annovis Bio's balance sheet accounts, such as liabilities and equity, to understand its overall financial position.
- Analyze the income statement and examine the company's revenue, expenses, and profits over time to determine its financial performance.
- Study the cash flow inflows and outflows to understand Annovis Bio's liquidity and solvency.
- Look at the growth rates in revenue, earnings, and cash flow over time to determine its potential for future growth.
- Compare Annovis Bio's financials to those of its peers to see how it stacks up and identify any potential red flags.
- Use valuation ratios to evaluate the company's financials using commonly used ratios such as the price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and enterprise value-to-earnings before interest, taxes, depreciation, and amortization (EV/EBITDA) ratio to determine if Annovis Bio's stock is overvalued or undervalued.
Annovis Bio February 3, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Annovis Bio help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Annovis Bio. We use our internally-developed statistical techniques to arrive at the intrinsic value of Annovis Bio based on widely used predictive technical indicators. In general, we focus on analyzing Annovis Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Annovis Bio's daily price indicators and compare them against related drivers.
| Information Ratio | (0.24) | |||
| Maximum Drawdown | 40.57 | |||
| Value At Risk | (7.21) | |||
| Potential Upside | 5.48 |
Additional Tools for Annovis Stock Analysis
When running Annovis Bio's price analysis, check to measure Annovis Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Annovis Bio is operating at the current time. Most of Annovis Bio's value examination focuses on studying past and present price action to predict the probability of Annovis Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Annovis Bio's price. Additionally, you may evaluate how the addition of Annovis Bio to your portfolios can decrease your overall portfolio volatility.